Details for New Drug Application (NDA): 202152
✉ Email this page to a colleague
The generic ingredient in QUETIAPINE FUMARATE is quetiapine fumarate. There are fifty-three drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the quetiapine fumarate profile page.
Summary for 202152
Tradename: | QUETIAPINE FUMARATE |
Applicant: | Accord Hlthcare |
Ingredient: | quetiapine fumarate |
Patents: | 0 |
Suppliers and Packaging for NDA: 202152
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
QUETIAPINE FUMARATE | quetiapine fumarate | TABLET;ORAL | 202152 | ANDA | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-7986 | 0615-7986-05 | 15 TABLET, FILM COATED in 1 BLISTER PACK (0615-7986-05) |
QUETIAPINE FUMARATE | quetiapine fumarate | TABLET;ORAL | 202152 | ANDA | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-7986 | 0615-7986-30 | 6 BLISTER PACK in 1 BOX, UNIT-DOSE (0615-7986-30) / 5 TABLET, FILM COATED in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 25MG BASE | ||||
Approval Date: | Mar 27, 2012 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 50MG BASE | ||||
Approval Date: | Mar 27, 2012 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 100MG BASE | ||||
Approval Date: | Mar 27, 2012 | TE: | AB | RLD: | No |
Complete Access Available with Subscription